nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—Signaling by GPCR—CXCL12—prostate cancer	0.000396	0.000396	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRB2—prostate cancer	0.000393	0.000393	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000391	0.000391	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—P4HB—prostate cancer	0.00039	0.00039	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CX3CL1—prostate cancer	0.00039	0.00039	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—JAK2—prostate cancer	0.000386	0.000386	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NRP1—prostate cancer	0.000386	0.000386	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—VAV3—prostate cancer	0.000383	0.000383	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000383	0.000383	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRB7—prostate cancer	0.00038	0.00038	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDE4D—prostate cancer	0.00038	0.00038	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—PIK3CA—prostate cancer	0.000378	0.000378	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MDM2—prostate cancer	0.000377	0.000377	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRB2—prostate cancer	0.000374	0.000374	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ITPR1—prostate cancer	0.000372	0.000372	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ERBB2—prostate cancer	0.000372	0.000372	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIST1H4H—prostate cancer	0.00037	0.00037	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL8—prostate cancer	0.00037	0.00037	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CB—prostate cancer	0.000367	0.000367	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—VAV3—prostate cancer	0.000365	0.000365	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNG5—prostate cancer	0.000361	0.000361	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCQ—prostate cancer	0.000361	0.000361	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000359	0.000359	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VIP—prostate cancer	0.000359	0.000359	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNRH1—prostate cancer	0.000359	0.000359	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ITPR1—prostate cancer	0.000354	0.000354	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL8—prostate cancer	0.000352	0.000352	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LPAR1—prostate cancer	0.000347	0.000347	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRP—prostate cancer	0.000347	0.000347	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDKN1B—prostate cancer	0.000344	0.000344	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLCB2—prostate cancer	0.000344	0.000344	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LRP2—prostate cancer	0.000344	0.000344	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—prostate cancer	0.00034	0.00034	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRB2—prostate cancer	0.00034	0.00034	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—P4HB—prostate cancer	0.000337	0.000337	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CX3CL1—prostate cancer	0.000337	0.000337	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—prostate cancer	0.000337	0.000337	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL2—prostate cancer	0.000337	0.000337	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—prostate cancer	0.000335	0.000335	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—VAV3—prostate cancer	0.000331	0.000331	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000331	0.000331	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCND1—prostate cancer	0.000328	0.000328	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRB7—prostate cancer	0.000328	0.000328	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDE4D—prostate cancer	0.000328	0.000328	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CTNNB1—prostate cancer	0.000325	0.000325	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ITPR1—prostate cancer	0.000321	0.000321	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIST1H4H—prostate cancer	0.00032	0.00032	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL8—prostate cancer	0.00032	0.00032	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—prostate cancer	0.000319	0.000319	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000318	0.000318	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDKN1A—prostate cancer	0.000318	0.000318	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PTEN—prostate cancer	0.000317	0.000317	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTHLH—prostate cancer	0.000315	0.000315	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFBR1—prostate cancer	0.000315	0.000315	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNG5—prostate cancer	0.000312	0.000312	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKR1C3—prostate cancer	0.00031	0.00031	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—prostate cancer	0.000309	0.000309	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKACB—prostate cancer	0.000308	0.000308	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EP300—prostate cancer	0.000302	0.000302	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—THBS1—prostate cancer	0.0003	0.0003	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PPP3CA—prostate cancer	0.0003	0.0003	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ANXA1—prostate cancer	0.000296	0.000296	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SRC—prostate cancer	0.000294	0.000294	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCZ—prostate cancer	0.00029	0.00029	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—prostate cancer	0.000286	0.000286	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CG—prostate cancer	0.000284	0.000284	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—prostate cancer	0.000283	0.000283	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PARP1—prostate cancer	0.00028	0.00028	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR4—prostate cancer	0.00028	0.00028	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CALCA—prostate cancer	0.000277	0.000277	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFBR1—prostate cancer	0.000272	0.000272	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTHLH—prostate cancer	0.000272	0.000272	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL12—prostate cancer	0.000271	0.000271	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKR1C3—prostate cancer	0.000267	0.000267	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKACB—prostate cancer	0.000266	0.000266	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MYC—prostate cancer	0.000263	0.000263	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—prostate cancer	0.000263	0.000263	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—THBS1—prostate cancer	0.000259	0.000259	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PPP3CA—prostate cancer	0.000259	0.000259	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CG—prostate cancer	0.000258	0.000258	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—prostate cancer	0.000258	0.000258	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ANXA1—prostate cancer	0.000256	0.000256	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP9—prostate cancer	0.000255	0.000255	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCZ—prostate cancer	0.000251	0.000251	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CD—prostate cancer	0.00025	0.00025	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCQ—prostate cancer	0.000247	0.000247	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGFR—prostate cancer	0.000247	0.000247	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CG—prostate cancer	0.000245	0.000245	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAP3K7—prostate cancer	0.000244	0.000244	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—KRAS—prostate cancer	0.000243	0.000243	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR4—prostate cancer	0.000242	0.000242	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PARP1—prostate cancer	0.000242	0.000242	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CALCA—prostate cancer	0.000239	0.000239	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF10—prostate cancer	0.000235	0.000235	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL12—prostate cancer	0.000234	0.000234	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRB2—prostate cancer	0.000232	0.000232	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—JAK2—prostate cancer	0.000229	0.000229	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAP2K1—prostate cancer	0.000228	0.000228	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CD—prostate cancer	0.000227	0.000227	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VAV3—prostate cancer	0.000226	0.000226	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CA—prostate cancer	0.000223	0.000223	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFBR2—prostate cancer	0.000223	0.000223	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CG—prostate cancer	0.000223	0.000223	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP9—prostate cancer	0.00022	0.00022	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ITPR1—prostate cancer	0.00022	0.00022	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CB—prostate cancer	0.000218	0.000218	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—prostate cancer	0.000216	0.000216	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CD—prostate cancer	0.000216	0.000216	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCQ—prostate cancer	0.000213	0.000213	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGFR—prostate cancer	0.000213	0.000213	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAP3K7—prostate cancer	0.000211	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—prostate cancer	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—prostate cancer	0.000209	0.000209	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—JAK2—prostate cancer	0.000208	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF10—prostate cancer	0.000203	0.000203	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LPL—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRB2—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2—prostate cancer	0.0002	0.0002	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDGFRB—prostate cancer	0.000199	0.000199	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—JAK2—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CB—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAP2K1—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CD—prostate cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VAV3—prostate cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ITGB3—prostate cancer	0.000194	0.000194	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFBR2—prostate cancer	0.000193	0.000193	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—prostate cancer	0.00019	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ITPR1—prostate cancer	0.00019	0.00019	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB3—prostate cancer	0.000189	0.000189	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR2—prostate cancer	0.000188	0.000188	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CB—prostate cancer	0.000188	0.000188	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—prostate cancer	0.000183	0.000183	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2—prostate cancer	0.000181	0.000181	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—prostate cancer	0.000181	0.000181	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—prostate cancer	0.000181	0.000181	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—prostate cancer	0.000181	0.000181	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—JAK2—prostate cancer	0.00018	0.00018	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LPL—prostate cancer	0.000174	0.000174	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIF1A—prostate cancer	0.000173	0.000173	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2—prostate cancer	0.000173	0.000173	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDGFRB—prostate cancer	0.000172	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CB—prostate cancer	0.000171	0.000171	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—prostate cancer	0.000169	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ITGB3—prostate cancer	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CAV1—prostate cancer	0.000167	0.000167	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KDR—prostate cancer	0.000165	0.000165	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—prostate cancer	0.000164	0.000164	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB3—prostate cancer	0.000163	0.000163	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR2—prostate cancer	0.000163	0.000163	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ESR1—prostate cancer	0.000161	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BAD—prostate cancer	0.000157	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2—prostate cancer	0.000157	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—prostate cancer	0.000156	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APC—prostate cancer	0.000152	0.000152	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	0.000152	0.000152	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGF—prostate cancer	0.000151	0.000151	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IRS1—prostate cancer	0.000151	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIF1A—prostate cancer	0.000149	0.000149	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GSK3B—prostate cancer	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—prostate cancer	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CAV1—prostate cancer	0.000144	0.000144	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INS—prostate cancer	0.000144	0.000144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KDR—prostate cancer	0.000143	0.000143	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CREBBP—prostate cancer	0.000141	0.000141	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—prostate cancer	0.000139	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ESR1—prostate cancer	0.000139	0.000139	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—prostate cancer	0.000139	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BAD—prostate cancer	0.000136	0.000136	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	0.000135	0.000135	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	0.000134	0.000134	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CG—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APC—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—KRAS—prostate cancer	0.000131	0.000131	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IRS1—prostate cancer	0.00013	0.00013	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGF—prostate cancer	0.00013	0.00013	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF2—prostate cancer	0.000128	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—prostate cancer	0.000126	0.000126	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GSK3B—prostate cancer	0.000126	0.000126	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INS—prostate cancer	0.000125	0.000125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JAK2—prostate cancer	0.000123	0.000123	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CREBBP—prostate cancer	0.000122	0.000122	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—prostate cancer	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MDM2—prostate cancer	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—prostate cancer	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB2—prostate cancer	0.000118	0.000118	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	0.000117	0.000117	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAP2K1—prostate cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CD—prostate cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CA—prostate cancer	0.000115	0.000115	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—prostate cancer	0.000114	0.000114	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—KRAS—prostate cancer	0.000113	0.000113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—prostate cancer	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF2—prostate cancer	0.000111	0.000111	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	0.00011	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—prostate cancer	0.000109	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	0.000108	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—prostate cancer	0.000107	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2—prostate cancer	0.000107	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—prostate cancer	0.000107	0.000107	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JAK2—prostate cancer	0.000106	0.000106	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCND1—prostate cancer	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CA—prostate cancer	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MDM2—prostate cancer	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	0.000103	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB2—prostate cancer	0.000102	0.000102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTEN—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—prostate cancer	9.84e-05	9.84e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—prostate cancer	9.69e-05	9.69e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EP300—prostate cancer	9.62e-05	9.62e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	9.36e-05	9.36e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SRC—prostate cancer	9.35e-05	9.35e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—prostate cancer	9.27e-05	9.27e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2—prostate cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—prostate cancer	9.21e-05	9.21e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—prostate cancer	9.11e-05	9.11e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCND1—prostate cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—prostate cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	8.94e-05	8.94e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—prostate cancer	8.76e-05	8.76e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	8.73e-05	8.73e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTEN—prostate cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—prostate cancer	8.5e-05	8.5e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MYC—prostate cancer	8.38e-05	8.38e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—prostate cancer	8.36e-05	8.36e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EP300—prostate cancer	8.31e-05	8.31e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—prostate cancer	8.2e-05	8.2e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SRC—prostate cancer	8.08e-05	8.08e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—prostate cancer	7.87e-05	7.87e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—prostate cancer	7.79e-05	7.79e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KRAS—prostate cancer	7.74e-05	7.74e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MYC—prostate cancer	7.24e-05	7.24e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—prostate cancer	7.22e-05	7.22e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	7.11e-05	7.11e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—prostate cancer	7.08e-05	7.08e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—prostate cancer	6.88e-05	6.88e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KRAS—prostate cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—prostate cancer	6.3e-05	6.3e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	6.15e-05	6.15e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—prostate cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—prostate cancer	5.81e-05	5.81e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—prostate cancer	5.44e-05	5.44e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—prostate cancer	5.02e-05	5.02e-05	CbGpPWpGaD
